Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hepatitis C

  Free Subscription


02.09.2019

1 Haemophilia
1 Hepatology
1 J Med Virol
1 J Viral Hepat
2 J Virol
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Haemophilia

  1. FRANSEN L, D'hondt P, Bielen R, Van den Ende N, et al
    Elimination of hepatitis C virus infection in patients with haemophilia in Belgium: A single-centre experience.
    Haemophilia. 2019 Aug 30. doi: 10.1111/hae.13829.
    PubMed     Text format     Abstract available


    Hepatology

  2. BARRE T, Protopopescu C, Bani-Sadr F, Piroth L, et al
    Elevated fatty liver index as a risk factor for all-cause mortality in HIV-HCV co-infected patients (ANRS CO13 HEPAVIH cohort study).
    Hepatology. 2019 Aug 29. doi: 10.1002/hep.30914.
    PubMed     Text format     Abstract available


    J Med Virol

  3. JANG ES, Kim KA, Kim YS, Kim IH, et al
    Real-life effectiveness and safety of the daclatasvir/asunaprevir combination therapy for genotype 1b chronic hepatitis C patients: an emphasis on the pretreatment NS5A resistance-associated substitution test.
    J Med Virol. 2019 Aug 26. doi: 10.1002/jmv.25575.
    PubMed     Text format     Abstract available


    J Viral Hepat

  4. CATLETT B, Lamoury FMJ, Bajis S, Hajarizadeh B, et al
    Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: a cohort study.
    J Viral Hepat. 2019 Aug 26. doi: 10.1111/jvh.13196.
    PubMed     Text format     Abstract available


    J Virol

  5. JOHNSON J, Freedman H, Logan M, Wong JAJ, et al
    A recombinant HCV genotype 1a E1/E2 envelope glycoprotein vaccine elicits antibodies that differentially neutralize closely related 2a strains through interactions of the N-terminal hypervariable region 1 of E2 with scavenger receptor B1.
    J Virol. 2019 Aug 28. pii: JVI.00810-19. doi: 10.1128/JVI.00810.
    PubMed     Text format     Abstract available

  6. CHEN TI, Hsu YK, Chou CY, Chen YH, et al
    Hepatitis C Virus NS3 Protein Plays a Dual Role in WRN-Mediated Repair of Non-Homologous End Joining.
    J Virol. 2019 Aug 28. pii: JVI.01273-19. doi: 10.1128/JVI.01273.
    PubMed     Text format     Abstract available


    PLoS One

  7. PEREZ AB, Chueca N, Macias J, Pineda JA, et al
    Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort.
    PLoS One. 2019;14:e0221231.
    PubMed     Text format     Abstract available

  8. CHUGH Y, Dhiman RK, Premkumar M, Prinja S, et al
    Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India.
    PLoS One. 2019;14:e0221769.
    PubMed     Text format     Abstract available

  9. UYEI J, Taddei TH, Kaplan DE, Chapko M, et al
    Setting ambitious targets for surveillance and treatment rates among patients with hepatitis C related cirrhosis impacts the cost-effectiveness of hepatocellular cancer surveillance and substantially increases life expectancy: A modeling study.
    PLoS One. 2019;14:e0221614.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: